Ftse Mib
33.067,99
-0,30%
DAX
19.261,75
-0,22%
S&P 500
6.000,40
-0,35%
NASDAQ
19.063,07
-0,59%
Bitcoin
96.895,66
5,35%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ENDRA Life Sciences Inc (NDRA) ENDRA Life Sciences Inc (NDRA) Notizie

ENDRA Life Sciences Inc

NDRA
6,1099
0,2699 (4,62%)
Ultimo aggiornamento: 20:53:25
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/11/202414:42EDGAR2Form 8-K - Current report
22/11/202414:00BWENDRA Life Sciences Regains Compliance with Nasdaq Minimum..
21/11/202423:14EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
19/11/202423:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/11/202422:06EDGAR2Form 8-K - Current report
15/11/202422:01EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
15/11/202415:24BWENDRA Life Sciences Reports Third Quarter 2024 Financial..
12/11/202414:00BWStudy Highlighting ENDRA Life Sciences’ TAEUS Technology in..
06/11/202414:00BWENDRA Life Sciences Further Strengthens TAEUS® Platform..
05/11/202414:00EDGAR2Form 8-K - Current report
29/10/202421:05EDGAR2Form 8-K - Current report
22/10/202414:00BWENDRA Life Sciences Activates TAEUS System to Initiate..
28/8/202423:09EDGAR2Form 8-K - Current report
28/8/202422:17BWENDRA Life Sciences Granted Extension to Regain Compliance..
23/8/202422:06EDGAR2Form 8-K - Current report
22/8/202422:14BWENDRA Life Sciences Reports Second Quarter 2024 Financial..
16/8/202422:10EDGAR2Form 8-K - Current report
16/8/202414:00BWENDRA Life Sciences Announces Reverse Stock Split
15/8/202423:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/8/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202422:05BWENDRA Life Sciences Reschedules Second Quarter Conference..
13/8/202415:24EDGAR2Form 8-K - Current report
13/8/202414:00BWENDRA Life Sciences Announces Leadership Changes
09/8/202414:02EDGAR2Form 8-K - Current report
07/8/202414:00BWENDRA Life Sciences to Report Second Quarter 2024 Financial..
17/7/202422:16EDGAR2Form 8-K - Current report
14/6/202422:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/6/202414:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/6/202414:00EDGAR2Form 8-K - Current report
05/6/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
04/6/202415:21BWENDRA Life Sciences Announces Pricing of $8.0 Million Public..
31/5/202422:21EDGAR2Form S-1/A - General form for registration of securities..
20/5/202414:05EDGAR2Form 8-K - Current report
20/5/202414:00BWENDRA Provides Update Following In-person Meeting with FDA
14/5/202422:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:17EDGAR2Form 8-K - Current report
14/5/202422:05BWENDRA Life Sciences Reports First Quarter 2024 Financial..
10/5/202423:18EDGAR2Form 8-K - Current report
10/5/202423:17EDGAR2Form S-1/A - General form for registration of securities..
07/5/202414:00BWENDRA Life Sciences to Report First Quarter 2024 Financial..
02/5/202414:00BWENDRA Life Sciences Strengthens Intellectual Property with..
28/3/202421:05BWENDRA Life Sciences Reports Fourth Quarter and Full Year..
21/3/202413:00BWENDRA Life Sciences to Report Fourth Quarter 2023 Financial..
27/2/202414:00BWENDRA Life Sciences Installs First TAEUS System in the UK
23/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202414:00BWNew ICD-10-CM Code by the World Health Organization Paves..
14/2/202414:30BWENDRA Life Sciences Bolsters TAEUS® System Intellectual..
29/11/202314:00BWENDRA Life Sciences Secures 39th U.S. Patent for TAEUS®..
Apertura: 5,71 Min: 5,6401 Max: 6,19
Chiusura: 5,84

La tua Cronologia

NASDAQ
NDRA
ENDRA Life Sciences
BIT
UB82CU
Unicredit Bank
BIT
UC5F1G
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network